AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpen M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alencure Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimpen M 1mg/500mg Tablet SR

Metformin/Glimepiride extended-release tablets (1mg/500mg) are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled glucose levels; abrupt cessation can lead to elevated blood sugar, increasing the risk of complications like kidney damage, vision loss, neuropathy, and limb amputation. Remember, it's one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to recognize its symptoms—sweating, lightheadedness, headache, tremors—and manage them accordingly. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Its suitability during pregnancy or breastfeeding requires medical consultation. Regular blood glucose monitoring is necessary, and your doctor might recommend blood tests to assess blood cell counts and liver function.

Uses of Glimpen M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimpen M 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimpen M 1mg/500mg Extended-Release tablets with food.

Common Side effects of Glimpen M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimpen M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimpen M 1mg/500mg SR tablet whole; do not crush, chew, or fracture it. Administer this medication with a meal.

How Glimpen M 1mg/500mg Tablet SR works:

Glipen M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimpen M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimpen M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimpen M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimpen M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. For those with severe kidney disease, this medication is contraindicated. Regular monitoring of renal function is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Glimpen M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, initiation should involve a low Glimpen M 1mg/500mg Tablet SR dose; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimpen M 1mg/500mg Tablet SR :

Should you forget a Glimpen M 1mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpen M 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Category Diabetes medication

FAQs on Glimpen M 1mg/500mg Tablet SR

Retain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Glimpen M 1mg/500mg Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more prevalent in individuals with kidney impairment, the elderly, and those who consume significant alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Glimpen M 1mg/500mg Tablet SR use and seek immediate medical attention.
Glipen M 1mg/500mg Extended-Release tablets contain glimepiride and metformin. This dual-action medication manages type 2 diabetes mellitus in adults. Effective blood sugar control is achieved when combined with a balanced diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glimpen M 1mg/500mg sustained-release tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged use of Glimpen M 1mg/500mg SR tablets can lead to Vitamin B12 deficiency due to impaired absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as numbness and tingling in the extremities), muscle weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, according to some studies, include supplemental Vitamin B12 at least annually.
Glimpen M 1mg/500mg SR tablets may induce hypoglycemia (low blood glucose). This can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Consuming alcohol concurrently with Glimpen M 1mg/500mg SR tablets is unsafe due to the risk of reduced blood glucose and subsequent hypoglycemia. Furthermore, this combination may heighten the likelihood of lactic acidosis.
Glimpen M 1mg/500mg Table...
37
MRP 45
17% off